IMPACT OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL INDUSTRY

The pharmaceutical sector is experiencing significant advancements with the integration of artificial intelligence (AI). Many pharmaceutical companies are adopting this technology to enhance the drug discovery and development phases, which will facilitate various research-oriented projects related to novel drug delivery approaches. The speed at which AI operates can reduce the time lag between the development of a drug product and its commercialization. Additionally, AI is being utilized in clinical trials to generate and interpret data collected from patients. In this article, we will discuss the various roles of artificial intelligence in drug development, tablet manufacturing, the design of antibiotic peptides, and clinical research. This overview highlights the significant impact that artificial intelligence has on the pharmaceutical industry. One of the most important advantages of AI is its ability to reduce costs associated with drug development. This, in turn, enhances returns on investment and may lead to lower prices for end users. The present review article explores topics such as drug discovery, diagnosis, prediction of new treatments, the development of novel peptides from natural foods, treatment and management of rare diseases, drug adherence, and dosage challenges related to the adoption of artificial intelligence in the pharmaceutical industry.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-15
DOI
https://doi.org/10.5281/zenodo.17616397
Primary Topic
vaccines and immunoinformatics approaches
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IMPACT OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL INDUSTRY

Zenodo (CERN European Organization for Nuclear Research)
vaccines and immunoinformatics approaches
article

IMPACT OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL INDUSTRY

article en

Abstract

The pharmaceutical sector is experiencing significant advancements with the integration of artificial intelligence (AI). Many pharmaceutical companies are adopting this technology to enhance the drug discovery and development phases, which will facilitate various research-oriented projects related to novel drug delivery approaches. The speed at which AI operates can reduce the time lag between the development of a drug product and its commercialization. Additionally, AI is being utilized in clinical trials to generate and interpret data collected from patients. In this article, we will discuss the various roles of artificial intelligence in drug development, tablet manufacturing, the design of antibiotic peptides, and clinical research. This overview highlights the significant impact that artificial intelligence has on the pharmaceutical industry. One of the most important advantages of AI is its ability to reduce costs associated with drug development. This, in turn, enhances returns on investment and may lead to lower prices for end users. The present review article explores topics such as drug discovery, diagnosis, prediction of new treatments, the development of novel peptides from natural foods, treatment and management of rare diseases, drug adherence, and dosage challenges related to the adoption of artificial intelligence in the pharmaceutical industry.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 43%
vaccines and immunoinformatics approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.